← Home / ABBOTT LABORATORIES (ABT)
Stock Analysis
ABBOTT LABORATORIES (ABT)
ABT
ABT · Healthcare • Medical Devices
104.26 -1.28%
Track ABT in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ABT price is:
52W Range Position
40%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 14:51 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 105.18. Holding above 96.38 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Positive
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
96.38
↗
Break Above
Confirmation improves above resistance.
105.18
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 96.38
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
16
●
Financial Results
HIGH
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott today announced financial results for the second quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
APR
27
●
Management / Board
MEDIUM
ABT board and management update
On April 24, 2026, Kevin Conroy was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.
8-K Filing • SEC EDGAR
What's Driving ABT?
📈 Technical recovery is improving
Momentum is Neutral. Watch 105.18 for confirmation and 96.38 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 96.38 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 16
Trigger
108.93
Invalidation
108.93
RSI(14)
62.8
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 96.38 and resistance at 105.18. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
ABT — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Fair
Fair valuation
The earnings multiple is in a moderate range.
Market Cap
$184.5B
Company size
EV
$195.0B
Debt-adjusted value
P/E
29.4
Reasonable
P/S
4.1
Balanced
P/B
3.5
Balanced
EV/Sales
4.3
Balanced
EV/EBIT
25.3
Reasonable
P/FCF
25.0
Reasonable
FCF Yield
4.00%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Improving
●
Profitability
Positive
≈
Cash Flow
Positive
⚖
Balance Sheet
Strong
💵 Revenue
11.16B
↗ Improving
📈 Net Income
1.08B
↗ Positive
🧮 EPS (Basic)
0.62
↗ Positive
ABBOTT LABORATORIES
Healthcare • Medical Devices
Related Opportunities